Tower Research Capital LLC (Trc) Hutchmed (China) LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,062 shares of HCM stock, worth $31,094. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,062
Previous 1,042
97.89%
Holding current value
$31,094
Previous $15,000
113.33%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding HCM
# of Institutions
57Shares Held
5.74MCall Options Held
0Put Options Held
0-
Schroder Investment Management Group London, X02.47MShares$37.2 Million0.03% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M909KShares$13.7 Million0.02% of portfolio
-
Jane Street Group, LLC New York, NY340KShares$5.13 Million0.0% of portfolio
-
State Street Corp Boston, MA318KShares$4.79 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.76 Million0.1% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.61B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...